The only safe and legal way to obtain retatrutide is through clinical trials, and any website or individual claiming to sell it outside of a trial is not offering a legitimate product
We are pleased that the FDA has accepted our submission and look forward to working with regulatory authorities on what would be the first oral GLP-1 treatment for obesity. Novo is advancing other oral drugs for treating obesity
Research has characterized cagrilintides capacity to engage these circuits additively with GLP-1 receptor agonists, providing a mechanistic basis for combinatorial metabolic research paradigms (Enebo et al., The Lancet, 2021)
It can be high blood pressure, high blood fat levels, or obstructive sleep apnoea
Ozempic has been in use since the FDA approved it in 2017
For GI goals, the oral animal evidence is genuinely interesting but still not matched by human clinical trials